Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 10Peritoneal Neoplasms 4Endometrial Neoplasms 4Uterine Cervical Neoplasms 3Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Carcinoma, Ovarian Epithelial 2Uterine Neoplasms 1Ovarian Cysts 1Obesity, Morbid 1Genital Neoplasms, Female 1Genital Diseases, Female 1Endometrial Adenocarcinoma 1Cholangiocarcinoma 1Breast Neoplasms 1Appendiceal Neoplasms 1Adnexal Diseases 1

Interventions

Mitomycin 7Hyperthermic Intraperitoneal Chemotherapy 5Oxaliplatin 4Doxorubicin 3Cisplatin 3Trastuzumab 2Leucovorin 2Irinotecan 2Fluorouracil 2tipifarnib 1sodium thiosulfate 1nilotinib 1motexafin lutetium 1irinotecan sucrosofate 1entinostat 1durvalumab 1dehydroftorafur 1Surveys and Questionnaires 1Referral and Consultation 1Quality of Life 1Psychiatric Rehabilitation 1Platinum 1Patient Reported Outcome Measures 1Paclitaxel 1Ondansetron 1Nutritional Status 1Molecular Diagnostic Techniques 1Mitozytrex 1Melphalan 1Laparoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Appendiceal Neoplasms × Laparoscopy × Gynecologic × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡